| NDC Code | 49281-723-10 |
|---|
| Package Description | 10 SYRINGE in 1 CARTON (49281-723-10) / .5 mL in 1 SYRINGE (49281-723-88) |
|---|
| Product NDC | 49281-723 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flublok Quadrivalent Northern Hemisphere |
|---|
| Non-Proprietary Name | Influenza A Virus A/west Virginia/30/2022 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/darwin/6/2021 (h3n2) Recombinant Hemagglutinin Antigen, Influenza B Virus B/austria/1359417/2021 Recombinant Hemagglutinin Antigen, And Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20230630 |
|---|
| End Marketing Date | 20240630 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125285 |
|---|
| Manufacturer | Sanofi Pasteur Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN |
|---|
| Strength | 45; 45; 45; 45 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|